pathological complete response in breast cancer

Release time ：Dec-26,2024

Pathological complete response (pCR) in breast cancer signifies that there are no viable cancer cells detected in the tumor tissue following treatment, as confirmed by pathological assessment. This outcome typically suggests that the treatment has been highly effective and the patient's prognosis is favorable.

In the context of breast cancer treatment, achieving a pCR is a critical measure for gauging treatment efficacy. Factors contributing to a pCR encompass the tumor's biological features, the patient's general health, and the selected treatment regimen. Typically, for patients with early-stage breast cancer, a combination of surgery with radiotherapy, chemotherapy, or endocrine therapy can result in a high rate of pCR. For those with advanced or metastatic breast cancer, while achieving a pCR is more challenging, it remains attainable through a multimodal therapeutic approach.

For individuals with breast cancer, it is imperative to engage in regular health check-ups and screenings. Upon diagnosis, it is crucial to select an appropriate treatment plan under a physician's guidance and adhere strictly to the prescribed treatment protocol. Additionally, maintaining healthy lifestyle habits and a positive mindset can significantly contribute to enhancing treatment outcomes and overall quality of life.